Regulation 284A Medicines with differing classification status in Great Britain and Northern IrelandF1
In the case of a medicinal product for sale or supply in Great Britain where the product concerned is not a prescription only medicine in Great Britain but is either—
(a)
a prescription only medicine in Northern Ireland; or
(b)
not authorised for sale or supply in Northern Ireland,
any advertisement to the public must include a statement that the medicinal product is not available without a prescription, or is not available for sale or supply, in Northern Ireland (as the case may be).
Annotations
Textual amendments
- F1
Reg. 284A inserted (31.12.2020) by S.I. 2019/775, regs. 1, 213A (as inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 170)